Advances in experimental medicine and biology, Год журнала: 2024, Номер unknown
Опубликована: Янв. 1, 2024
Язык: Английский
Advances in experimental medicine and biology, Год журнала: 2024, Номер unknown
Опубликована: Янв. 1, 2024
Язык: Английский
Journal of Clinical Investigation, Год журнала: 2024, Номер 134(10)
Опубликована: Май 14, 2024
Molecular characterization of vascular anomalies has revealed that affected endothelial cells (ECs) harbor gain-of-function (GOF) mutations in the gene encoding catalytic α subunit PI3Kα (PIK3CA). These PIK3CA are known to cause solid cancers when occurring other tissues. PIK3CA-related anomalies, or "PIKopathies," range from simple, i.e., restricted a particular form malformation, complex, presenting with hyperplasia phenotypes, including overgrowth spectrum. Interestingly, development PIKopathies is by fluid shear stress (FSS), physiological stimulus caused blood lymph flow. findings implicate PI3K mediating EC responses FSS conditions characteristic lymphatic and capillary vessel beds. Consistent this hypothesis, increased signaling also contributes cerebral cavernous malformations, disorder affects low-perfused brain venous capillaries. Because GOF activity its partners excellent drug targets, understanding PIK3CA's role may inform therapeutic strategies normalize diseased state. This Review focuses on discusses current dysregulation particularly affect regions vasculature. We discuss recent surprising linking fast-flow arteriovenous malformations hereditary hemorrhagic telangiectasias.
Язык: Английский
Процитировано
6European Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown, С. 117621 - 117621
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Advances in experimental medicine and biology, Год журнала: 2024, Номер unknown
Опубликована: Янв. 1, 2024
Язык: Английский
Процитировано
0